嘉戎技術(301148.SZ):公司的反滲透膜技術、耐酸鹼和耐溶劑膜分離技術在新能源材料、半導體、濕法冶煉等新興行業都具有一定的應用潛力
格隆匯4月17日丨嘉戎技術(301148.SZ)在投資者互動平台表示,公司主營業務為膜分離裝備、高性能膜組件等產品的研發、生產和銷售,應用於工業清潔生產和高濃度污廢水處理服務。公司的反滲透膜技術、耐酸鹼和耐溶劑膜分離技術在新能源材料、半導體、濕法冶煉等新興行業都具有一定的應用潛力,公司目前與相關企業在新能源材料電解液、廢酸及貴金屬回收方面進行對接,未來將繼續儲備相關技術,為新能源鋰電池(固體及半固態電池)生產工藝的降本增效貢獻自己的力量。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.